TechnoMark News

  Market Industry Reports (MIR) has published a new report titled  “ Plasma Fractionation Market   – Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2030.”  According to the report, the global plasma fractionation market is estimated to be over US$ 25 billion in 2019. It is anticipated to grow at a CAGR of ~6.0% from 2019 to 2030. Plasma fractionalization is the use of biotechnology to produce numerous protein therapeutics that help treat different human disorders. Plasma products comprise multiple coagulation factors, polyvalent and hyperimmune, immunoglobulins, protease inhibitors, anticoagulants, and albumin. Combination of these products in plasma fractionalization play an important role in curing several disorders including chronic illnesses, rare disorders, immune deficiency diseases, and few neurological disorders. These products are essentially obtained from the human plasma and are ideally amalgamated with industrial process to make it of ...

Plasma fractionation refers to the process of separation, extraction, and purification of plasma. Human plasma contains the large variety of proteins, however, only a few of these proteins are help in producing therapeutic plasma products. Plasma is used in prevention and treatment of various life threatening diseases caused by trauma, immunologic disorders, and infections. Plasma fractionation process is majorly used in treating protein deficiency condition in healthcare applications. The proteins extracted from the plasma are majorly categorized into three main classes: immunoglobulins which are useful in treatment of autoimmune disorders and increasing the immune response of the body, clotting factors which are help in treatment of blood disorders such as haemophilia, and the albumins which are useful in conditions of decreased albumin levels or during fluid loss. Plasma fractionation process is carried by different criteria such as solubility of the products, and their physical an...